Scynexis

SCYXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$43.778 M

$4.40 -1.34%

Close of 21 Sept 2026

Revenue

$20.6M

#2980 by revenue

Earnings

-$8.61M

Loss-making

Shares outstanding

9,949,609

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#356Mereo BioPharma GroupMREO$45.0M
#357Grace TherapeuticsGRCE$44.2M
#358ScynexisSCYX$43.8M
#359NanoviricidesNNVC$43.1M
#360ImmutepIMMP$42.9M

What if Scynexis were worth as much as…

Open the what-if tool →

Gold $30.3T

$3,042,738

Per share 691,531× higher

Bitcoin $1.72T

$172,851.38

Per share 39,284× higher

Nvidia $5.48T

$550,761.14

Per share 125,173× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Scynexis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.